Xtant Medical to Issue Third Quarter 2021 Financial Results on November 12, 2021
Xtant Medical Holdings, Inc. (NYSE American: XTNT) will announce its Q3 financial results for the period ending September 30, 2021, on November 12, 2021, prior to market opening. A conference call featuring Sean Browne, President and CEO, and Greg Jensen, CFO, is scheduled for 9:00 AM ET the same day. Investors can listen to the call via dial-in or webcast. Xtant Medical specializes in surgical solutions for spinal disorders and offers a range of orthobiologics and spinal implant systems.
- Scheduled Q3 financial results release on November 12, 2021.
- Conference call for detailed review of results.
- None.
BELGRADE, Mont., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2021, before the open of the financial markets on Friday, November 12, 2021.
Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Friday, November 12 at 9:00 AM ET to review results.
Conference Details
Conference Date: Friday, November 12, 2021 - 9:00 AM ET
Conference dial-in: 866-682-6100
International dial-in: 862-298-0702
Conference Call Name: Xtant Medical Q3 2021 Financial Results
Webcast Registration: Click Here
Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com
FAQ
When will Xtant Medical release its Q3 2021 financial results?
What time is the Xtant Medical Q3 2021 conference call?
How can I access the Xtant Medical Q3 conference call?
What is the focus of Xtant Medical Holdings?
